The latest Tweets from Hartaj Singh (@hartajsingh). “ Or the exquisite delicate thin curve of the new moon in spring; ” W. Whitman, Miracles. New York. Hartaj Singh works at Oppenheimer. Before joining Oppenheimer, he was the director/biotechnology analyst for BTIG and a portfolio manager for Tecumseh. Hartaj Singh is Managing Director and Senior Analyst covering Biotechnology. Prior to joining Oppenheimer, Hartaj was Managing Director and Senior.
|Published (Last):||14 July 2007|
|PDF File Size:||7.10 Mb|
|ePub File Size:||12.17 Mb|
|Price:||Free* [*Free Regsitration Required]|
Shaul holds an M.
Oppenheimer Analyst Bios
Earlier, at Lehman Brothers, he was instrumental in the relaunch of the company’s mid- and large-cap coverage. Mohan joined us from Stephens, Inc. Mark Breidenbach Emerging Biotechnology. He has an M.
His coverage focuses on managed care, hospitals, nursing homes, home health, hospice, emergency services, and related healthcare services. He sungh holds an M. Brian is quoted often in the financial press and serves frequently as a quest expert on various financial news channels, such as Bartaj and Bloomberg. Jed received a B. Jason began his career in equity research at Schroder Wertheim.
Most recently, she founded her own research and consulting firm catering to Life Sciences companies focusing in and around oncology. Prior to joining the firm, John was Senior Market Strategist at Ticonderoga Securities where he provided all macro, market outlook, and strategy ideas to the firm and its clients. New articles related to this author’s research. His research is focused on finding disruptive macro and micro software trends. Prior to joining the firm, Chris attended Columbia Business School and started his Wall Street career on the buy-side as an analyst.
Ari graduated from Rutgers University with a B. While at ClinTrials Research, he coordinated clinical management for an anti-epileptic new drug application NDAand was the youngest clinical project manager to lead an NDA filing.
Please see Overview for more details. Molecular Therapy 9 5, Brian graduated from Creighton University with a B. John Parks is Managing Director and Director of Research and oversees Oppenheimer’s overall research strategy and product.
The American journal of cardiology 94 7, Glenn holds a B.
Leland also has both sell-side and buy-side experience and began his career on Cowen’s biotechnology zingh team, where he provided sole coverage focused in the small and mid-cap segment. Rick received an international M.
Prior to joining the firm, he worked as a financial analyst and market researcher for Eurofon, Inc. Brian holds a B.
He joined the firm inand has been covering the sector since He also is a Chartered Financial Analyst and was a C. Leah holds a B. InJohn was named Head of Equity Research, a position he continues to hold today.
In this interview, Singh shares his predictions for the rest of with The Life Sciences Reportand identifies several companies to hold for potentially big returns. John began his Wall Street career at the First Boston Corporation as an investment banker and later as an institutional salesman. Metal Matrix omposites material.
Expert – Hartaj Singh
He has been with Oppenheimer sincefirst working with Brian Nagel on the Hardlines and Broadlines retail team. Tim researches a broad range of communications and cloud companies with a focus on emerging services and applications. Erica joined the firm in as an associate analyst in the Travel and Leisure space and subsequently covered e-Commerce companies before moving into her current position. He served for five years in the Special Forces of the Israeli Defense Forces, where he held the rank of lieutenant.
She has been with the firm sinceoriginally working on the sinth and brokers team alongside Chris Kotowski. bartaj
Prior to joining Oppenheimer, he was on the equity research team at Roth Capital Partners covering the eCommerce, Internet, and Media sectors. Hartan addition, in andMichael was ranked the 1 brokerage analyst for Medical Care by Forbes Magazine. He has been a CFA charterholder since Prior to joining Oppenheimer, Andrew worked in equity research at Ardour Capital and also in investment banking at Deutsche Bank.
He started his career in various finance and accounting positions singg Lannett Company and Lordi Consulting. Ian graduated from the University of Michigan with a B.
Solar Energy Industries Association for 5 years. The following articles are merged in Scholar.